Cipla had a good run in the last bull cycle. It has retraced well during recent correction and now consolidating in a range for last few months. The volumes are consistent, most of the dips have been bought into immediately so there's consistent interest in this stock. Weekly MA's are converging and its also forming a rounding pattern. Last few days, pharma index has been trending strongly and Cipla has contributed as well.
The only downside is the narrative around tariff as Cipla significant portion of revenues from US, hence one needs to be cautious. On such counters, I personally, prefer a very tight SL.
Disclaimer: Details shared for study and learning purpose. Trade after consulting your advisor or your own analysis.
The only downside is the narrative around tariff as Cipla significant portion of revenues from US, hence one needs to be cautious. On such counters, I personally, prefer a very tight SL.
Disclaimer: Details shared for study and learning purpose. Trade after consulting your advisor or your own analysis.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.